• Bangalore
  • 5 February 2013
  • News
  • By Narayan

Dr Bernstein: India should increase its visibility

India has the best opportunity in biotechnology if it follows important factors like pre-competitiveness, where pooling of resources is necessary to understand diseases and this is made possible only by industry-academia collaboration

web-image

Dr Karen Bernstein, co-founder and chairman, BioCentury, USA, speaking at a session on Bangalore India Bio

"India fits in perfectly as a global biotech hub provided it can increase generic medicine for both internal and other emerging markets, high level of differentiation, chart a clear path to early exit, bring-in capital efficiency especially in venture level, develop professional, nimble and entrepreneurial management of companies," said Dr Karen Bernstein, co-founder and chairman, BioCentury, USA.

Speaking at a session on how India can leverage the biotech industry and the challenges for India in this sector at the Bangalore India Bio 2013 organized by the Department of Information Technology, Bio-Technology and Science and Technology, Government of Karnataka on February 4, 2013, Dr Karen Bernstein, said, "India has the best opportunity in biotechnology if it follows important factors like - pre-competitiveness where pooling of resources is necessary to understand diseases and this is only possible by industry-academic collaboration. There exists major gaps in basic sciences that are key to enabling innovations in novel therapeutics. Improving productivity through collaboration is needed. The key to success lies in focusing and addressing specific areas of science."

She further said, "In India, the problem is about misalignment of time line. The solution for this is differentiating single project companies from therapeutic platform companies and a novel corporate structure. In future, the biotech R&D will be globalized in multiple tracks, more presumptive collaborations will take place, system will be driven by patients, and the need to adopt to world austerity."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

SelfV Survivor Stories Concludes with a Resounding Message

Tuesday, 21 Feb 2017   |   Health Care Global Enterprises Ltd. (HCG)

Business Wire India Celebrating the spirit of cancer survivors, Pink Hope Cancer Patient Support Group

BusinessWire India.com - Pharmaceutical

Bwi-logo

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

BusinessWire India.com - Medical Devices

Bwi-logo

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

SelfV Survivor Stories Concludes with a Resounding Message

Tuesday, 21 Feb 2017   |   Health Care Global Enterprises Ltd. (HCG)

Business Wire India Celebrating the spirit of cancer survivors, Pink Hope Cancer Patient Support Group

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X